Background Candida auris has emerged globally as an MDR nosocomial pathogen in ICU
patients. Objectives We studied the antifungal susceptibility of C. auris isolates (n = 350) from …

In New Delhi, India, candidemia affected 15 critically ill coronavirus disease patients admitted
to an intensive care unit during April–July 2020. Candida auris accounted for two thirds of …

Zygomycosis is an emerging infection worldwide. A study was conducted to understand its
spectrum in the Indian scenario. All patients diagnosed for invasive zygomycosis at a tertiary …

Objectives: To identify the risk factors associated with Candida auris candidaemia, as this
fungus now poses a global threat. Methods: We performed a subgroup analysis of a previously …

Background: As fungal endophthalmitis is an emerging challenge, the study was carried out
to determine the prevalence and the spectrum of fungal agents causing endophthalmitis …

Gram-positive pathogens mainly, Staphylococcus aureus, Enterococcus and coagulase-negative
Staphylococcus, are developing increasing resistance to glycopeptides that pose a …

Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide.
Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole …

Background The ongoing pandemic of coronavirus disease 2019 (COVID-19) has overwhelmed
healthcare facilities and raises an important novel concern of nosocomial transmission …

Objectives The emergence of fluconazole resistance in Candida parapsilosis healthcare-associated
infections has recently been increasingly reported. Antifungal susceptibility profiles …

Second wave of COVID-19 pandemic in India came with unexpected quick speed and
intensity, creating an acute shortage of beds, ventilators, and oxygen at the peak of occurrence. …